Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Office Actions › Diamond Therapeutics Inc. › 18814163
Last updated: April 21, 2026
Application No. 18/814,163

Untitled Application

Unknown
Filed
1600
Examiner
SHOMER, ISAAC
Art Unit
1612
Tech Center
Diamond Therapeutics Inc.
Assignee
Diamond Therapeutics Inc.
OA Round
4 (Non-Final)
63%
Grant Probability
Moderate
4-5
OA Rounds
2y 11m
To Grant
94%
With Interview

Interview Optional

— +31.0% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 63% grant rate with +31.0% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.
Based on 1164 resolved cases, 2023–2026

Examiner Intelligence

SHOMER, ISAAC View full profile →
Grants 63% of resolved cases
63%
Career Allow Rate
733 granted / 1164 resolved
+3.0% vs TC avg
Strong +31% interview lift
Without
With
+31.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
62 currently pending
Career history
1226
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
44.9%
+4.9% vs TC avg
§102
12.2%
-27.8% vs TC avg
§112
23.5%
-16.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1164 resolved cases

Prosecution Timeline

1600
Application Filed
Oct 08, 2024
Non-Final Rejection
Oct 28, 2024
Interview Requested
Nov 04, 2024
Examiner Interview Summary
Nov 18, 2024
Response Filed
Nov 25, 2024
Non-Final Rejection
Feb 07, 2025
Interview Requested
Feb 20, 2025
Examiner Interview Summary
Feb 27, 2025
Response Filed
Feb 27, 2025
Response after Non-Final Action
Mar 06, 2025
Final Rejection
Sep 10, 2025
Request for Continued Examination
Sep 10, 2025
Response after Non-Final Action
Oct 03, 2025
Response after Non-Final Action
Oct 08, 2025
Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/054,131
Patent 12589073
LEVERAGING LIPID-PROTEIN INTERACTIONS TO ENGINEER SPATIAL ORGANIZATION IN CELL-FREE SYSTEMS
3y 4m to grant Granted Mar 31, 2026
17/864,524
Patent 12582118
ANTIMICROBIAL COATING MATERIAL FOR SURFACE COATING
3y 8m to grant Granted Mar 24, 2026
18/221,262
Patent 12576029
NONCOMPETITIVE RECEPTOR-TARGETED VACCINE DELIVERY TO PLASMACYTOID DENDRITIC CELLS
2y 8m to grant Granted Mar 17, 2026
18/547,664
Patent 12576160
BISPECIFIC NANOPARTICLE SYSTEMS FOR TARGETING CANCER CELLS
2y 6m to grant Granted Mar 17, 2026
18/651,154
Patent 12576058
METHODS FOR DECREASING INJURIES ASSOCIATED WITH INTRAOPERATIVE HYPOTENSION
1y 10m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

4-5
Expected OA Rounds
63%
Grant Probability
94%
With Interview (+31.0%)
2y 11m
Median Time to Grant
High
PTA Risk
Based on 1164 resolved cases by this examiner. Grant probability derived from career allow rate.

Ready to respond to this office action?

IP Author drafts your complete OA response — amendments, arguments, and claim strategy — in minutes, not days.

Start Drafting Your Response →

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month